Philip Wells
Overview
Explore the profile of Philip Wells including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
2522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shaw J, Kumar V, Mallick R, Carrier M, Ilich A, Key N, et al.
Thromb Res
. 2020 Oct;
196:437-443.
PMID: 33065408
Introduction: Risk assessment models are used to stratify cancer patients according to their underlying risk of VTE. The CATS score has been shown to enhance VTE risk stratification as compared...
12.
Nithianandan H, Reilly A, Tritschler T, Wells P
Thromb Res
. 2020 Aug;
195:195-208.
PMID: 32745746
Purpose: To evaluate the value of biomarkers to prognosticate outcomes in patients with pulmonary embolism among studies of sound methodical quality. Methods: Ovid MEDLINE, Embase, CENTRAL, and non-indexed citations were...
13.
Ilich A, Kumar V, Henderson M, Mallick R, Wells P, Carrier M, et al.
Thromb Res
. 2020 Aug;
191 Suppl 1:S31-S36.
PMID: 32736776
Background: The mechanisms surrounding cancer-associated venous thromboembolism (VTE) are not well characterized. AVERT, a randomized placebo controlled thromboprophylaxis study in ambulatory cancer patients, provides a unique opportunity to gain insights...
14.
Moores L, Tritschler T, Brosnahan S, Carrier M, Collen J, Doerschug K, et al.
Chest
. 2020 Jun;
158(3):1143-1163.
PMID: 32502594
Background: Emerging evidence shows that severe coronavirus disease 2019 (COVID-19) can be complicated by a significant coagulopathy, that likely manifests in the form of both microthrombosis and VTE. This recognition...
15.
16.
Parsons N, Stallard N, Parsons H, Wells P, Underwood M, Mason J, et al.
Trials
. 2019 Dec;
20(1):694.
PMID: 31815651
Background: There is widespread concern across the clinical and research communities that clinical trials, powered for patient-reported outcomes, testing new surgical procedures are often expensive and time-consuming, particularly when the...
17.
Miranda S, Benhamou Y, Wells P, Carrier M
Thromb Haemost
. 2019 Oct;
119(11):1886-1887.
PMID: 31600806
No abstract available.
18.
Nithianandan H, Reilly A, Wells P
Thromb Res
. 2019 Feb;
176:8-10.
PMID: 30753971
No abstract available.
19.
Kearney R, McKeown R, Stevens S, Parsons N, Parsons H, Wells P, et al.
BMJ Open
. 2018 Dec;
8(12):e027242.
PMID: 30567826
Introduction: Each year in the UK over 120 000 people fracture their ankle. It is not known what the best rehabilitation strategy is for these people. Traditionally standard care has...
20.
Truong V, Huang S, Dennis J, Lemire M, Zwingerman N, Aissi D, et al.
Sci Rep
. 2017 Sep;
7(1):11207.
PMID: 28894120
Efficient interventions to reduce blood triglycerides are few; newer and more tolerable intervention targets are needed. Understanding the molecular mechanisms underlying blood triglyceride levels variation is key to identifying new...